Multi-center, Open-label, Prospective, Randomized, Parallel Group Study Investigating an Intensified Enteric-coated Mycophenolate Sodium (EC-MPS) Dosing Regimen in Comparison to a Standard Dosing Regimen of EC-MPS in Combination With Cyclosporin Microemulsion and Corticosteroids in de Novo Renal Transplant Patients.
Latest Information Update: 29 Aug 2013
At a glance
- Drugs Mycophenolate sodium (Primary) ; Ciclosporin; Corticosteroids
- Indications Renal transplant rejection
- Focus Pharmacokinetics; Therapeutic Use
- Sponsors Novartis
- 19 Aug 2010 Results were reported at the 23rd International Congress of the Transplantation Society.
- 19 Aug 2010 Tolerability outcomes were reported at the 23rd International Congress of the Transplantation Society.
- 15 Aug 2010 Prespecified pooled analysis (see also 700020735) presented at the 23rd International Congress of the Transplantation Society.